
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 949 | 975 | 985 | 1294 | 1399 | 2218 |
Fund Return | -5.1% | -2.49% | -1.49% | 8.96% | 6.94% | 8.29% |
Place in category | - | - | - | - | - | - |
% in Category | 100 | 98 | 99 | 97 | 95 | 54 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr Adv | 6.61B | -5.21 | 8.76 | 7.96 | ||
Manulife Glbl Eq Cl Sr F | 6.61B | -4.63 | 10.10 | 9.30 | ||
Manulife Glbl Eq Cl Sr FT6 | 6.61B | -4.63 | 10.10 | 9.30 | ||
Manulife Glbl Eq Cl Sr T6 | 6.61B | -5.21 | 8.75 | 7.96 | ||
Manulife Div incm Fd Sr T6 | 6.03B | 2.69 | 9.91 | 8.88 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Global Innovators Class F | 16.81B | 4.16 | 32.76 | - | ||
Capital Group Glbal Equity Fd F CAD | 14.26B | 3.97 | 18.57 | 11.05 | ||
Capital Group Glbal Equity Fd A CAD | 14.26B | 3.40 | 17.27 | 9.83 | ||
Capital Group Glbal Equity Fd D CAD | 14.26B | 3.82 | 18.19 | 10.59 | ||
EdgePoint Global Portfolio Series A | 12.93B | 4.11 | 12.09 | 7.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Publicis Groupe | FR0000130577 | 5.89 | 89.32 | +0.43% | |
Marsh McLennan | US5717481023 | 4.88 | 210.90 | -1.25% | |
Microsoft | US5949181045 | 4.70 | 505.82 | +0.56% | |
Booking | US09857L1089 | 4.05 | 5,675.53 | -1.57% | |
Alimentation Couche Tard | CA01626P1484 | 3.93 | 68.10 | -1.16% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Strong Sell |
Technical Indicators | Neutral | Strong Sell | Strong Sell |
Summary | Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review